Sector
PharmaceuticalsOpen
₹288.2Prev. Close
₹293.25Turnover(Lac.)
₹4,866.19Day's High
₹304.2Day's Low
₹27852 Week's High
₹052 Week's Low
₹0Book Value
₹0Face Value
₹2Mkt Cap (₹ Cr.)
4,861.2P/E
200.7EPS
1.5Divi. Yield
0.33No Record Found
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Equity Capital | 16.14 | 16.14 | 16.14 | 16.14 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 895.36 | 820.29 | 780.94 | 709.28 |
Net Worth | 911.5 | 836.43 | 797.08 | 725.42 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Revenue | 510.39 | 492.24 | 473.28 | 484.63 |
yoy growth (%) | 3.68 | 4 | -2.34 | 4.58 |
Raw materials | -193.84 | -213.87 | -175.64 | -179.19 |
As % of sales | 37.97 | 43.44 | 37.11 | 36.97 |
Employee costs | -65.89 | -58.88 | -58.37 | -58.21 |
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Profit before tax | 120.25 | 103.82 | 118.83 | 94.7 |
Depreciation | -44.25 | -44.13 | -44.13 | -35.34 |
Tax paid | -33.1 | -45.34 | -32.04 | -31.52 |
Working capital | 85.06 | 133.26 | -3.47 | 130.15 |
Other operating items |
Y/e 31 Mar | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 3.68 | 4 | -2.34 | 4.58 |
Op profit growth | 15.25 | -15.91 | 4.15 | 16.71 |
EBIT growth | 9.86 | -8.56 | 27.54 | 17.88 |
Net profit growth | 49.02 | -32.61 | 37.37 | 40.9 |
Particulars (Rupees in Crores.) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|---|
Gross Sales | 1,633.86 | 1,561.85 | 1,560.35 | 1,373.23 | 1,267.56 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,633.86 | 1,561.85 | 1,560.35 | 1,373.23 | 1,267.56 |
Other Operating Income | 79.83 | 34.2 | 28.39 | 12.07 | 4.65 |
Other Income | 26.13 | 26.54 | 86.91 | 24.87 | 17.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
JANMEJAY RAJNIKANT VYAS
Whole-time Director
DEOHOOTI JANMEJAY VYAS
Director
ASHOK CHANDRAKANT GANDHI
Director
RAJENDRA SHANTILAL SHAH
Director
SANJAY SHAILESHBHAI MAJMUDAR
Managing Director & CFO
ARPIT JANMEJAY VYAS
Director
SUBIR KUMAR DAS
Director
MARK CHRISTOPHER GRIFFITHS
Company Secretary
SHRIMA GAURANGBHAI DAVE
Bhadr-Raj Chambers,
Swastik Cross Road Navrangpura,
Gujarat - 380009
Tel: 91-79-26443053/26445807
Website: http://www.dishmangroup.com
Email: dishman@dishmangroup.com
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Dishman Pharmaceuticals and Chemicals Ltd is a recognized supplier of cost-effective, high quality chemical services and products to the global pharmaceutical and chemical industry. They are involved ...
Read More
Reports by Dishman Pharmaceuticals and Chemicals Ltd Merged
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.